Not sure why you hold stock if expecting an inevitable CRL?
Me, I will stick with the company advising of a successful mock
inspection , Lonza Houston 5 FDA approvals, unmet need and
4 year survival results.
Oh , and that the FDA overruled their ODAC committee re
efficacy
Bit of a rant - but mock inspection on a modern Lonza plant is a big tick .
Reg
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection, page-165
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.00 |
Change
0.043(4.43%) |
Mkt cap ! $1.147B |
Open | High | Low | Value | Volume |
96.5¢ | $1.01 | 96.5¢ | $1.927M | 1.950M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 20294 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 40989 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 90023 | 1.000 |
12 | 157710 | 0.995 |
13 | 150837 | 0.990 |
9 | 77609 | 0.985 |
6 | 106253 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 90348 | 13 |
1.015 | 42998 | 9 |
1.020 | 120947 | 10 |
1.025 | 5200 | 1 |
1.030 | 5202 | 4 |
Last trade - 10.56am 14/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online